Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02012426
Other study ID # LDS-2013-SLW
Secondary ID KRISTAL No.
Status Completed
Phase N/A
First received December 10, 2013
Last updated May 31, 2017
Start date January 2014
Est. completion date May 2016

Study information

Verified date May 2017
Source University of Leeds
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the current study is to demonstrate that a commercial weight management diet (i.e. low energy density) influences satiation, hunger and satiety and leads to lower energy intake during ad-libitum meals and over a full day. We further seek to demonstrate the sustainability of this effect following 12- week weight loss on the weight management program.

- We hypothesise that formulated (low energy) meals will lead to decreased hunger, greater fullness and reduced desire to eat compared to standard meals.

- We hypothesise that the commercial weight management program will lead to greater weight loss compared to control program.

- We hypothesise that formulated meals (high consumer acceptance) will improve hedonic control over eating (lower wanting for high fat food)

- We hypothesise that the commercial weight management program will improve hedonic control over eating (reduced experience food cravings)


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date May 2016
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- BMI of 28 - 45 kg/m2

- Reporting an interest in weight loss, not actively participating in a commercial weight loss program,

- Not increased physical activity levels in the past 2-4 weeks

- Able to eat most everyday foods and fruits and vegetables

- Written informed consent to be given

Exclusion Criteria:

- Significant health problems that could cause confounding effects between intervention and control.

- Taking any medication or supplements known to affect appetite or weight within the past month and/or during the study

- Pregnant, planning to become pregnant or breastfeeding

- History of anaphylaxis to food

- Known food allergies or food intolerance

- Smokers and those who have recently ceased smoking

- Participants receiving systemic or local treatment likely to interfere with evaluation of the study parameters

- Those who have previously taken part in a commercial weight loss program in the last 6 months? .

- Participants who work in appetite or feeding related areas

- Participants unable to consume foods used in the study

- Participants who have had bariatric surgery

- Participants with a history of eating disorder

- Presence of untreated hypothyroidism

- Inability to fully comply with intervention or study procedures

- Insufficient English language skills to complete study questionnaires

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Weight management program


Locations

Country Name City State
United Kingdom University of Leeds Leeds West Yorkshire

Sponsors (1)

Lead Sponsor Collaborator
University of Leeds

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Food diary Intervention adherence and compensation through 1) food diary analysis. Week 0 and week 12
Other Accelerometer Intervention adherence and compensation through accelerometer analysis. Week 0 and week 12
Other Interview Detailed feedback on participant experience of commercial weight management program through qualitative interview and marketing survey. Week 12
Primary Test Meal Energy Intake Measured reductions in ad-libitum energy intake following consumption of formulated test meal in comparison to control. Week 0 and week 12
Primary 24h Energy Intake Measured reduction in total within-day energy intake following consumption of formulated meals in comparison to control Week 0 and week 12
Primary Appetite sensations Measured reduction in hunger and increase in satiety quotient following consumption of formulated test meal in comparison to equi-energetic control Week 0 and week 14
Primary Food preference Measured changes in food preference and liking and wanting profiles for food (HF Week 0 and week 14
Secondary Body Weight Measured change in weight and energy balance parameters over a 12 week period following participation in commercial weight management program compared to control group. Weekly from week 0 to week 12
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2